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Postoperativeatrialﬁbrillation(POAF)iscommonamongsurgicalpatientsandassociatedwithaworseoutcome.Pathophysiology
of POAF is not fully disclosed, and several perioperative factors could be involved. Direct cardiac stimulation from perioperative
use of catecholamines or increased sympathetic outﬂow from volume loss/anaemia/pain may play a role. Metabolic alterations,
such as hypo-/hyperglycaemia and electrolyte disturbances, may also contribute to POAF. Moreover, inﬂammation, both systemic
and local, may play a role in its pathogenesis. Strategies to prevent POAF aim at reducing its incidence and ameliorate global
outcome of surgical patients. Nonpharmacological prophylaxis includes an adequate control of postoperative pain, the use
of thoracic epidural analgesia, optimization of perioperative oxygen delivery, and, possibly, modulation of surgery-associated
inﬂammatory response with immunonutrition and antioxidants. Perioperative potassium and magnesium depletion should be
corrected. The impact of those interventions on patients outcome needs to be further investigated.
1.Introduction
Postoperative atrial ﬁbrillation (POAF) is common both
after cardiothoracic and noncardiothoracic surgery [1]. In
patients undergoing cardiothoracic surgery an incidence
of 16–46% has been reported, depending on the extent
of postoperative monitoring used and the speciﬁc surgical
procedures [2–9]. In patients undergoing noncardiothoracic
surgery, reported incidence of POAF varies between 0.4%
and 12% [9, 10]. POAF can be observed during all the
postoperative course, with a peak between the second and
ﬁfth postoperative day [11].
Risk of developing POAF may be related to several
epidemiologicalandperioperativepredictivefactors.General
factors include older age, male gender, obesity, preexisting
congestive heart failure, chronic renal failure, or COPD
which are all risk factors for POAF [12, 13]. In noncardio-
thoracicsurgery,predictorsforPOAFarepreexistingvalvular
disease and asthma, intra-abdominal and major vascular
procedures, and intraoperative hypotension [14].
Even though POAF can be self-limiting, it may be
associated with hemodynamic derangements, postopera-
tive stroke, perioperative myocardial infarction, ventricular
arrhythmias, and heart failure [15, 16]. In many reports,
development of POAF is associated with a longer hospital
stay, greater morbidity and mortality, and increased costs
[11, 17]. In patients at risk of POAF, additional interven-
tions, both pharmacological and nonpharmacological, are
suggested in order to prevent its clinical consequences [11].
Amiodarone, beta-blockers, and magnesium supplementa-
tion are the mainstay of pharmacological prophylaxis in
patients at risk [11]. Nonpharmacological prophylaxis may
include several interventions during all the perioperative
time. The aim of this study is to review nonpharmacological
prophylaxis of POAF in light of its complex pathophysiology.
2.Pathophysiology and
Nonpharmacologic Treatment
The electrophysiological mechanisms involved in POAF
are not fully disclosed. Classically, atrial ﬁbrillation can
be linked to alteration in atrial refractoriness, slowing of
atrial conduction, and/or reentry in wavelets of excitation
in the atria [18, 19]. It has been proposed that patients
who develop POAF may already have an electrophysiological
substrate for this arrhythmia before surgery [18]. Several
perioperative factors would be able to trigger atrial ﬁbril-
lation. In patient undergoing cardiothoracic surgery, the
intraoperativetraumaperse,manipulationoftheheart,local
inﬂammation with or without pericarditis, and elevation in2 ISRN Cardiology
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Figure 1: Pathophysiology of postoperative atrial ﬁbrillation (see text for details).
atrial pressure from postoperative ventricular stunning may
all predispose to alterations in refractoriness and/or local
reentry [18]. In all surgical patients, atrial ﬁbrillation can be
also related to speciﬁc factors, such as direct cardiac stimula-
tion from perioperative use of catecholamines or reﬂex sym-
pathetic activation from volume loss/anaemia/pain, fever,
and hypo-/hyperglycaemia [20–22]. There is also evidence
that inﬂammation, both systemic and local, may play a role
in POAF pathogenesis (see Figure 1)[ 23]. However, exact
mechanisms of POAF after noncardiothoracic surgery are
not fully understood [10].
2.1. Mechanical Factors, Pain, and Sympathetic Stimulation.
Atrial ﬁbrillation is commonly described after pulmonary or
esophageal surgery [24–30]. During cardiothoracic surgery,
mechanical manipulation of heart and pericardium leads to
a local tissue trauma and local inﬂammatory response which
may both lead to POAF [31–33]. Heart manipulation may
be responsible also for a direct and local imbalance between
sympatheticandparasympathetictone,(seeFigure 1).Direct
injury to myocardial sympathetic nerve ﬁbers may alter the
autonomic modulation of atrial myocardial cells, increasing
their sensitivity to catecholamines, thus contributing to
POAF. Systemic sympathetic tone can be increased as well,
due to a systemic inﬂammatory response to surgical trauma
and pain, and circulating catecholamines may act on the
sensitized atrial myocardium shortening refractory period,
causing atrial reentry or promoting triggered automaticity
to produce arrhythmias [32]. Thus, perioperative beta-
blockade exerts similar eﬀects and can play a role in limiting
postoperative atrial arrhythmias [34].
Pain itself triggers a sympathetic response which con-
tributes to postoperative arrhythmias (see Figure 1). Pain-
induced sympathetic outﬂow and the imbalance between
sympathetic and parasympathetic activity produce atrial
ectopic beats and, in susceptible patients, trigger POAF
(see Figure 1)[ 35]. There is experimental evidence that
adequate postoperative pain relief is associated with a
reduced incidence of POAF. In a prospective case-control
study, Hooten and colleagues found a higher incidence of
POAF in patients after thoracic surgery with poor control of
postoperative pain [36].
Thoracic epidural anesthesia (TEA) may reduce inci-
dence of atrial arrhythmias (see Figure 2)[ 37]. Reasons
include a direct negative chronotropic eﬀect on heart, a
better coronary blood ﬂow and myocardial oxygenation, and
reduced sympathetic outﬂow from perioperative pain (see
Figure 2)[ 38]. In cardiothoracic surgery, postoperative TEA
with local anesthetics, for example, bupivacaine, induces
a variable degree of sympathetic blockade, which can be
responsible for the observed reduction in postoperative car-
diactachyarrhythmias[32].Thereisalsoageneralagreement
on the fact that TEA allows a better control on postoperative
pain, thus reducing the release of catecholamines (see
Figure 2)[ 32, 39, 40]. Moreover, TEA can reduce myocar-
dial sensitivity to circulating catecholamines [41]. A TEA-
mediated increase of myocardial vagal tone can also be partly
responsible for its chronotropic eﬀects (see Figure 2)[ 38].
Simeoforidou and colleagues measured heart rate variability
in patients who underwent thoracotomy and showed a
decreased cardiac sympathetic outﬂow in those patients on
TEA compared to those who received patient-controlled i.v.
morphine [42]. Intraoperative TEA can prevent POAF as
well. Scott and colleagues reported a reduced incidence of
postoperativeatrialarrhythmiasinpatientswhoundergonea
combined general-epidural anesthesia as compared to those
who received general anesthesia alone (10.2% versus 22.3%)
[37].
Interestingly, some authors state that atrial arrhythmias
could be linked to a postoperative loss of parasympathetic
state, which exerts inhibitory eﬀect on atrial myocardium,
and not to an enhanced sympathetic tone. In a recent,
small trial, Jiang and colleagues found that, after pulmonary
resection, a patient-controlled infusion of opioids (fentanyl
and tramadol) can reduce postoperative supraventricular
arrhythmias more than patient-controlled epidural analgesia
with ropivacaine [35]. They argue that restoring parasym-
pathetic stimulation on atrial myocardium, through opioidISRN Cardiology 3
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Figure 2: Nonpharmacological prophylaxis of postoperative atrial ﬁbrillation (see text for details).
infusion,mightberesponsibleforthisresult.However,actual
evidenceisthatepiduralanalgesiaissuperiortosystemicopi-
oid in terms of outcome for patients undergoing cardiotho-
racicand major abdominal procedures, including abdominal
vascular surgery and colonic cancer resection [43].
2.2. Inﬂammation and Anti-Inﬂammatory Strategies. During
surgical trauma, a systemic inﬂammatory response is evi-
dent, and its intensity mirrors the degree of surgical stress
[44]. Takenaka et al. demonstrated that serum levels of
inﬂammatory markers, such as interleukin-6 (IL-6) and C-
reactive protein (CRP), correlated with clinical determinants
of surgical stress, such as duration of surgery, length of
surgical wound, or intensity of pain [45].
There is mounting evidence showing the inﬂuence of
systemic inﬂammation in the pathogenesis of atrial ﬁbril-
lation (see Figure 1). Circulating levels of proinﬂammatory
cytokines, like IL-6 and TNF-alpha, are elevated in patients
with atrial arrhythmias [23]. Higher levels of complement,
CRP or white blood cells, can be found in patients who
develop POAF when compared to controls [46]. Considering
patients undergoing elective cardiac surgery, Lamm and
colleagues demonstrated that a more pronounced increase
in postoperative markers of inﬂammation independently
predicts development of POAF [47]. Furthermore, local
myocardial inﬂammation may contribute to pathogenesis of
POAF (see Figure 1)[ 48].
Both systemic and local inﬂammation may foster an
oxidative injury with release of reactive oxygen species
(ROS).ROScaninduceanelectricalmyocardialremodelling,
characterized by a diminished eﬀective refractory period to
actionpotential, thus precipitating POAF (see Figure 2)[49].
Indeed, there are experimental evidences that a oxidative
injury occurs in myocardial tissues of patients with atrial
ﬁbrillation [50], and many studies have shown increased
levels of serum myocardial oxidation markers, such as
peroxynitrite and superoxide, in ﬁbrillating patients after
surgery [50–52]. NAD(P)H oxidase, the main source of
superoxide in the atria, was found at higher levels in POAF-
developing patients than in those who do not develop this
arrhythmia [53]. Based on these experimental observations,
perioperative supplementation of antioxidant could con-
tribute in reducing POAF (see Figure 2).
Antioxidants, including vitamin C, N-acetylcysteine,
statins, are an heterogeneous group of molecules which
have proved to decrease serum levels of molecular markers
of cellular oxidative stress in patients undergoing cardiac
surgery. They also can reduce the incidence of POAF (see
Figure 2)[54,55].Furthermoreithasbeenhypothesizedthat
one of the mechanisms by which classic anti-AF drugs act
is related with the ability to ROS scavenging and protection
against membrane lipid peroxidation [56]. Numerous lines
of evidence show that a reinforcement of the antioxidant
defence system diminishes the vulnerability of myocardium
to the eﬀect of increased ROS. In support of this view,
prevention of POAF by classic antioxidants such as N-
acetylcysteine and statins has been reported [57]. In a
prospective case-control study, Carnet and colleagues tested
the eﬀects of perioperative vitamin C supplementation in
POAF incidence on 43 patients undergoing cardiac surgery.
Incidence of POAF in the treated group was 16% versus
35% of the control group [58]. There is also evidence that
oral administration of ascorbic acid in the perioperative
period would be able to decrease POAF incidence about
50% [58]. Despite these lines of evidence, perioperative
supplementation of antioxidants is not routinely undertaken
[59].
Modulating the perioperative inﬂammatory response
through the administration of immunonutrients could
potentially reduce postoperative complications, including
POAF (see Figure 2)[ 60]. Polyunsaturated omega-3 fatty
acids (PUFAs) have been suggested to have direct eﬀects on
cardiac microsomal calcium/magnesium adenosine triphos-
phatase and voltage-gated sodium channels [61]. Clinical
studies have shown that PUFAs reduce the incidence of atrial
ﬁbrillation as well as ventricular arrhythmias in patients4 ISRN Cardiology
with myocardial infarction [62] and implanted deﬁbrillators
[63]. In a prospective randomized prospective survey, Cal` o
et al. [64]. randomized 160 patients undergoing CABG to
receiveeitherPUFA2g/dayforatleast5dayspostoperatively.
The authors demonstrated that PUFAs were able to reduce
the incidence of POAF by 65%. This eﬀect was associated
with a signiﬁcant reduction in hospital length of stay
(P = .017).
Renal continuous venovenous hemoﬁltration (CVVH)
and blood depuration techniques are increasingly employed
to reduce or modulate the systemic inﬂammatory response
in critically ill patients [65]. CVVH has been employed to
reduce the inﬂammatory response associated with cardio-
thoracic surgery [66]. Indeed, in patients undergoing post-
operative renal replacement therapy, hemoﬁltration eﬄuent
has been shown to contain tumor necrosis factor-alpha,
interleukin-6, C3a, and C5a complexes [66–68]. Intraop-
erative CVVH during cardio-pulmonary bypass (CPB) has
been shown to remove low-molecular-weight molecules
from the plasma, including inﬂammatory mediators like
cytokines [66, 67]. Due to the role of inﬂammation in the
pathogenesis of POAF, it has been hypothesized that CVVH
during CPB might decrease the incidence of AF after cardiac
surgery [69]. However, timing of perioperative CVVH is
still a matter of debate. AF typically occurs 48–96h after
surgery, and a short period of attenuating the inﬂammatory
cascade during the operation probably has little beneﬁt
in preventing more delayed complications. In fact, it has
been shown that C-reactive protein levels do not peak until
postoperative day 2, and complement C3b/c levels undergo
a secondary elevation between postoperative days 2 and 4
[46, 70]. This late peak in circulating levels of inﬂammatory
mediators likely further negates the eﬀects of a therapy
conﬁned to the intraoperative period [69]. Furthermore, for
patients undergoing noncardiac surgery, routine application
of CVVH is not indicated.
2.3. Volemia. Development of POAF can be related to hypo-
volemia and hypotension (see Figure 1)[ 71]. Blood and/or
ﬂuid loss decrease venous return to right atrium, thus reduc-
ing stroke volume and cardiac output. The same alterations
canbetheconsequenceofanesthesia-inducedcardiovascular
depression. The decreased tissue oxygen delivery stimulates
the release of endogenous catecholamines. In hypovolemic
patients, hemodynamic variations are ﬁnalized to maintain
an adequate tissue perfusion and oxygenation, through an
increase in heart rate, peripheral vascular resistance, and
venomotor tone. These eﬀects aim to restore venous return
towardtheheartandtomaintainanadequatestrokevolume.
Secretion of catecholamines by the sympathetic system is
crucial. In the surgical patient, loss of ﬂuids and hemorrhage
can lead to reﬂex sympathetic hyperactivity, which may have
proarrhythmic on heart [72]. Noradrenaline, dopamine, or
dobutamine infusion may play a role as well. Thus, in
postoperative patients, new-onset POAF should prompt a
diﬀerential diagnosis to rule out surgical bleeding.
Intraoperative hypovolemia, together with hypoxia and
anemia, may lead to a relative ischemia of atrial cells
and myocardial conduction tissue, altering the cell electric
properties and leading to arrhythmias, both ventricular and
supraventricular [26, 73, 74].
Hypervolemia is related to POAF through a mecha-
nism of mechanical stimulation of the right atrium: the
“mechanical-electrical feedback” [71, 75–78]. It has been
shown that onset and duration of atrial cells’ membrane
action potential are aﬀected by changes in the length of
the ventricular cells [78–80]. Thereafter, myocardial stretch,
in both isolated and in situ hearts, has been shown to
induce ventricular arrhythmias because of the occurrence of
transient depolarizations and shortening of the refractory
period [81]. The large volume of ﬂuid infused during peri-
operative period, especially in general and vascular surgery,
could increase atrium diastolic volume and reversibly reduce
compliance, altering electrical properties of atrial cells [82].
ConsequentincreasedexcitabilitymaytriggerPOAF[83,84].
Indeed, the Atrial Fibrillation Suppression Trial II
showed that patients who developed POAF after cardiotho-
r a c i cs u r g e r yr e c e i v e d1 l .o fi . v .ﬂ u i d sm o r et h a nc o n t r o l s
in the ﬁrst 5 postoperative days. In addition, net ﬂuid
balance on second postoperative day, in which POAF had
the highest rate of incidence, was an independent predictor
of POAF (OR 6.4, 95% CI 1.4 to 29.1, P = .014)
[82].
In light of these results, maintaining a state of euvolemia
is indicated to reduce the risk of POAF (see Figure 2). A
judicious perioperative use of i.v. replacement ﬂuids, with
patient-targeted infusions and hemodynamic monitoring,
would be necessary to achieve optimal tissue perfusion
without overloading the heart and lungs [85, 86].
2.4. Hypoxia. Hypoxia has a causative role for perioperative
supraventricular arrhythmias. Hypoxia leads to a reduced
oxygen arterial content, that is, reduced oxygen delivery to
tissues. Therefore, increased sympathetic activity aims to
increase heart rate and enhance vascular tone to increase
cardiacoutputandcompensateforreducedarterialoxygena-
tion. In postsurgical patients, hypoxia-related hyperactivity
of sympathetic system may be responsible for development
of POAF (see Figure 1). Acute hypoxia-driven pulmonary
vasoconstriction can acutely overload right ventricle and
cause right atrial overdistension and myocardial stretch. This
may trigger POAF. Moreover, acute hypoxia is able to cause
ischemic injury to atrial cells and myocardial conduction
tissues, altering the electric properties of cells’ membrane
and triggering atrial arrhythmias (see Figure 1). Thus, POAF
may be associated with postoperative respiratory failure, and
all strategies aiming at the optimization of gas exchange can
reduce the risk for POAF [87].
Chronic hypoxia, like in COPD or obesity, is a well-
established risk factor for atrial ﬁbrillation in the peri-
operative period. Pathophysiology of POAF in patients
with chronic hypoxia includes polyglobulia and hypoxia-
inducedpulmonaryvasoconstriction[88].Increasesinblood
viscosity and pulmonary resistance induce an increase in
right ventricular afterload, thus overloading right ventricle
and atrium. This may lead to atrial cells’ stretch and
predispose to the electrophysiological alterations typical of
POAF.Moreover,chronichypercarbiaincreasesatrialvolumeISRN Cardiology 5
and pressure through sympathetic-mediated vasoconstric-
tion [89].
MooeandcolleaguesfoundthatPOAFhadasigniﬁcantly
higher incidence in patients with obstructive sleep apnoea
syndromes (OSASs) than in controls (39% versus 18%) [90].
Interestingly, multivariate analysis showed that predictors
of AF recurrence were the magnitude of nocturnal oxygen
desaturation and the proportion of time asleep with an
oxygen saturation lower than 90%.
Kanagala et al. found that relapse of atrial ﬁbrillation
one year after electrical cardioversion was signiﬁcantly and
markedly higher in patients who had untreated OSAS than
in patients who had been treated (82% versus 53%) [91]. In
a retrospective study, Patel and et al. compared the incidence
of postoperative complications in patients with OSAS. Inci-
dence of POAF was greater in the OSAS group patients than
the control group ones, and this value decreased strongly in
all OSA patients treated with preoperative CPAP [92].
Optimization of oxygenation in patients with chronic
respiratory failure would be associated with a reduced risk of
POAF (see Figure 2). Possible strategies may include periop-
erative noninvasive ventilation, physiotherapy, or incentive
spirometry [93]. In selected cases, preoperative hyperbaric
oxygenation can be considered to reduce after CABG com-
plications, including POAF [87].
2.5. Anemia. Perioperative anemia is a known risk factor
of POAF. Anemia, especially acute anemia, produces an
intense adrenergic activation and an increase in cardiac
output ﬁnalized to increase cardiac output and compensate
for reduced oxygen arterial, thus maintaining tissue oxy-
gen delivery. The anemia-related adrenergic response may
trigger POAF in predisposed patients (see Figure 1). Not
uncommonly, atrial ﬁbrillation may be one of the ﬁrst signs
of acute postoperative bleeding [94]. Another mechanism
linking anemia to POAF is a relative ischemic injury to
atrialmyocytesandmyocardialconductioncells,withaltered
membrane function and subsequent arrhythmic events (see
Figure 1).
Several studies indicate therefore anemia as an important
risk factor in the development of postoperative atrial
ﬁbrillation [18]. Despite that hemoglobin optimization is
usually undertaken in the routine clinical care of surgical
patients, there is not deﬁnitive evidence showing that
increasing hemoglobin concentration up to a deﬁned level
necessarily improves outcome and reduces incidence of
POAF. In cardiothoracic surgery, on the contrary, there
is increasing evidence that packed red cell transfusion
actually increases incidence of POAF [95]. In cardiothoracic
patients, Sood and colleagues showed that patients who
received postoperative transfusions had a 2-fold increase
in their risk of developing POAF. According to the authors,
the mechanism underlying this phenomenon may be
related to a transfusion-related inﬂammatory response
a n dt oﬂ u i do v e r l o a d[ 95]. Thus, despite that no deﬁnitive
evidence exists, it seems reasonable that a minimum level
of hemoglobin concentration should be set and achieved
for each patients, based on clinical conditions and type of
surgery, to optimize oxygen delivery (see Figure 2). However,
overzealous use of blood products should be discouraged in
view of associated adverse eﬀects [96].
2.6.Hypothermia. Postoperativehypothermiahasbeenasso-
ciated with increased sympathetic activity and POAF (see
Figure 1)[ 71]. In a prospective randomized study, Sun et
al. demonstrated that the sympathetic response depends on
the depth of hypothermia [97]. At lower temperatures, wider
changes in plasma norepinephrine and neuropeptide Y were
observed during the rewarming phase. Moreover, new-onset
atrial ﬁbrillation during the postoperative period occurred
more often in patients who were actively cooled to 28◦C
(moderate hypothermic group) compared with those who
were only cooled to 34◦C (mild hypothermic group) (16.6%
versus 66.7%, P = .03). Interestingly, recent guidelines on
POAF prevention by the American College of Chest Physi-
cians recommend the use of mild hypothermia for reducing
theincidenceofatrialﬁbrillationaftercardiothoracicsurgery
[37]. It has been argued that mild hypothermia suppresses
sympathetic nerve activity during rewarming following
surgery, thus preventing neurohormonal mediated atrial
ﬁbrillation [98]. However, in noncardiothoracic surgery,
maintaining normothermia is essential to prevent POAF and
other cardiovascular complications (see Figure 2)[ 99].
2.7. Metabolic Alterations. Surgery-related metabolic alter-
ations can trigger POAF in predisposed patients [18].
Marked metabolic acidosis, with consequent catecholamines
secretion and myocardial sensitization, directly causes
supraventricular and ventricular arrhythmias [94].
Perioperative hypoglycaemia can be associated with an
increased susceptibility and longer duration of POAF (see
Figure 1)[ 22]. In diabetic patients this eﬀect is even more
pronounced and hypoglycaemia should be considered as a
potential reversible cause of atrial ﬁbrillation in diabetic
patients [100]. Actually, during hypoglycaemic episodes,
the intense adrenergic stimulation is thought to cause
arrhythmias [101].
Perioperative hyperglycaemia can also be detrimental
for myocardial function, particularly after cardiothoracic
surgery [102]. This is because elevated glucose concentration
may induce damage to myocardial cells’ membrane damage
and alter its electrical properties, thus leading to POAF
[103]. High blood glucose may generate free radicals and
cause oxidative injury to myocardial cell, inducing apop-
tosis and, consequently, arrhythmias [104]. The myocar-
dial oxidative injury can also be induced and maintained
by hyperglycaemia-related secretion of cytokines, which
enhances perioperative inﬂammatory (see above). Thus,
even though strict glycemic control is still debated in the
surgical and critically ill patient, avoiding excessive hypergly-
caemia seems to be important to reduce cardiovascular com-
plications after cardiothoracic surgery (see Figure 2)[ 105].
Hypothyroidism and subclinical hypothyroidism have
adverse eﬀects on the cardiovascular system and may cause
cardiac arrhythmias and POAF (see Figure 1), particularly
after CABG [106], and thyroid dysfunction is considered
a predictor of poor prognosis for patients after surgery
[107]. Pathogenesis of AF in patients with low levels of6 ISRN Cardiology
T3 hormone is not completely understood; a potential
explanation was suggested from in vitro studies which
showed that a low T3 state was associated to alterations of
intracellular compartments for Ca2+ ion and generation of
altered ionic ﬂows across myocardial cell membrane [108].
It is well known that patients undergoing surgery, and
especially cardiac procedure, have low free T3 levels due
to decreased cardiac 5 -monodeiodinase activity [109]. This
“low T3 syndrome” can be further worsened by preoperative
hypothyroidism or preoperative subclinical hypothyroidism
and is associated with POAF [106]. Furthermore, Klemperer
et al., in a prospective randomized study, demonstrated
that administration of exogenous T3 was able to reduce the
incidence of AF in patients undergoing CABG [110].
Thus, detection of preoperative thyroid dysfunction
could be important for patients undergoing surgery, par-
ticularly cardiothoracic, and preoperative thyroid hormone
replacement therapy or supplementation would be beneﬁcial
in reducing incidence of POAF (see Figure 2)[ 106].
2.8. Electrolytes. In a retrospective survey, 23% of patients
whodevelopedsupraventriculararrhythmiaafternoncardiac
surgery had a metabolic derangement and an electrolytic
imbalance [94], and a tight preoperative control of elec-
trolyte imbalance is recommended to decrease incidence of
POAF (see Figure 2)[ 111].
Potassium and magnesium deﬁciencies have all been
associated with the development of atrial ﬁbrillation in
postoperative period (see Figure 1)[ 71].
In a prospective observational study, Walsh et al. [112]
reported the incidence of and the risk factor for arrhythmias
following noncardiothoracic surgery. Pre- and postoperative
serum potassium levels were signiﬁcantly lower in arrhyth-
mia group than in control group (69% versus 24%; P<
.005). These patients may have had intracellular potassium
depletion at the time of the arrhythmia [113].
Magnesium deﬁciency may precipitate arrhythmias
[114]. The use of magnesium in the preoperative and
early postoperative periods is highly eﬀective in reducing
incidence of POAF after CABG [115], and magnesium
can be considered as the antiarrhythmic drug of choice
in depleted patients [11]. On the other hand, magnesium
sulphate infusion does not decrease the rate of postoperative
atrial ﬁbrillation during the early postoperative period in
normomagnesemic patients [116].
3. Conclusions
Postoperativeatrialﬁbrillationiscommonandcontributesto
a worse outcome of surgical patient. Pathogenesis of POAF is
multifactorial. The increased sympathetic outﬂow, related to
hypovolemia, anemia, hypoxia, or pain, can elicit new-onset
atrial ﬁbrillation in surgical patients. Pericardial manipu-
lation and local inﬂammation during thoracic and cardiac
surgery may contribute, as does the surgery-related systemic
inﬂammatory response. Finally, metabolic derangements
such as perioperative hypothyroidism or hyperglycemia
and electrolyte disturbances may also contribute to POAF
pathogenesis. Thus, beyond pharmacological prophylaxis,
several strategies can be implemented to reduce incidence
of POAF, depending on which factor is involved. An
adequate control of postoperative pain is mandatory, and
the use of thoracic epidural analgesia for thoracic and upper
abdominal surgery can induce a functional sympathetic
block with negative chronotropic eﬀect. The optimization of
perioperative oxygen delivery, with a judicious and patient-
tailored use of perioperative noninvasive ventilation and
blood transfusions, may reduce the incidence of POAF. Peri-
operativeﬂuidmanagementshouldbetargetedtoavoidboth
hypo- and hypervolemia. Possibly, modulation of surgery-
associated inﬂammatory response with immunonutrition
and antioxidants may help reducing incidence of POAF.
Perioperative depletion ofpotassium andmagnesiumshould
becorrected.Furtherresearchismandatorytoclarifytherole
of those interventions on incidence of POAF and outcome of
surgical patients.
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